4.5 Article

Exendin-4 Increases the Expression of Hypoxia-Inducible Factor-1α in Rat Islets and Preserves the Endocrine Cell Volume of Both Free and Macroencapsulated Islet Grafts

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Surgery

Beneficial Effects of Desferrioxamine on Encapsulated Human Islets-In Vitro and In Vivo Study

V. Vaithilingam et al.

AMERICAN JOURNAL OF TRANSPLANTATION (2010)

Article Medicine, Research & Experimental

Hypoxia-inducible factor-1α regulates β cell function in mouse and human islets

Kim Cheng et al.

JOURNAL OF CLINICAL INVESTIGATION (2010)

Article Cell & Tissue Engineering

Long-Term Metabolic and Hormonal Effects of Exenatide on Islet Transplant Recipients With Allograft Dysfunction

Raquel N. Faradji et al.

CELL TRANSPLANTATION (2009)

Article Cell & Tissue Engineering

Establishment of Mouse Pancreatic Stem Cell Line

Hirofumi Noguchi et al.

CELL TRANSPLANTATION (2009)

Article Cell & Tissue Engineering

Beneficial Role of Pancreatic Microenvironment for Angiogenesis in Transplanted Pancreatic Islets

Joey Lau et al.

CELL TRANSPLANTATION (2009)

Article Surgery

Islet transplantation for brittle type 1 diabetes: The UIC protocol

A. Gangemi et al.

AMERICAN JOURNAL OF TRANSPLANTATION (2008)

Article Biochemistry & Molecular Biology

GLP-1 receptor signaling protects pancreatic beta cells in intraportal islet transplant by inhibiting apoptosis

Kentaro Toyoda et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)

Article Medical Laboratory Technology

The portal immunosuppressive storm - Relevance to islet transplantation?

AMJ Shapiro et al.

THERAPEUTIC DRUG MONITORING (2005)

Article Endocrinology & Metabolism

Exendin-4 normalized postcibal glycemic excursions in type 1 diabetes

J Dupré et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)

Article Immunology

Inflammation blockade improves pancreatic islet function

Z Yang et al.

TRANSPLANTATION PROCEEDINGS (2004)

Article Medicine, General & Internal

Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen.

AMJ Shapiro et al.

NEW ENGLAND JOURNAL OF MEDICINE (2000)